Clinical Evidence-based Guideline Stuttering 2020: what has changed and why

Abstract

The Dutch Evidence-based Clinical Guideline Stuttering provides answers to a number of key questions about assessment, treatment, referral and aftercare of people who stutter. The 2014 guideline was revised in 2020. The starting point of this revision was not to formulate new key questions, but to update existing ones. The working group responsible for this revision consisted of representatives of the Dutch Association for Speech Therapy and Phoniatrics (NVLF), the Dutch Association for Stuttering Therapy (NVST)
and the patient association Dutch Stuttering Association Demosthenes (Demosthenes).

Relevant new publications were evaluated and rated for quality of evidence. The guideline users were asked to comment on the former 2014 guideline. These comments
were taken into account.
This paper explains the changes in the recommendation for each key question with examples of the supporting evidence. Recommendations are given for future research
on diagnostics and treatment of stuttering.